Background
The Ad26.COV2.S vaccine was highly effective against severe-critical coronavirus disease 2019 (Covid-19), hospitalization, and death in the primary phase 3 efficacy analysis.Methods
We conducted the final analysis in the double-blind phase of our multinational, randomized,...